Differences in Dihydrotetrabenazine Isomer Concentrations Following Administration of Tetrabenazine and Valbenazine

Por Skor, Heather, Smith, Evan B., Loewen, Gordon, O’Brien, Christopher F., Grigoriadis, Dimitri E., Bozigian, Haig
Publicado no Drugs R D (2017)

Preclinical Characterization of PF-00868554, a Potent Nonnucleoside Inhibitor of the Hepatitis C Virus RNA-Dependent RNA Polymerase

Por Shi, Stephanie T., Herlihy, Koleen J., Graham, Joanne P., Nonomiya, Jim, Rahavendran, Sadayappan V., Skor, Heather, Irvine, Rebecca, Binford, Susan, Tatlock, John, Li, Hui, Gonzalez, Javier, Linton, Angelica, Patick, Amy K., Lewis, Cristina
Publicado em 2009